Phoreus Biotechnology, Inc.


Phoreus Biotech is a pioneering life science company specializing in the development of next-generation peptide nanocarriers for drug, vaccine, and therapeutic delivery. With a focus on innovative nanotechnology platforms like BAPC, CAPC, and APC, the company aims to revolutionize treatment efficacy, stability, and safety across human, animal, and environmental health sectors. Their mission is to advance targeted, safe, and effective delivery systems that overcome limitations of traditional carriers, enabling new possibilities in medicine, agriculture, and biotechnology.

Industries

biotechnology
health-care
health-diagnostics

Nr. of Employees

small (1-50)

Phoreus Biotechnology, Inc.

Olathe, Kansas, United States, North America


Products

Peptide-based transfection reagent kit

A peptide nanocarrier transfection kit supplied with reagent components and a protocol for forming peptide/nucleic acid complexes and transfecting diverse cell lines; guidance provided for N/P ratio optimization and complex formation.

Peptide nanocarrier platform portfolio

Set of peptide-based nanocarrier platforms including branched amphipathic peptide capsules, corralling amphipathic peptide colloids, and amphipathic peptide capsules designed for encapsulation and targeted delivery of nucleic acids, proteins, small molecules and agricultural actives.


Services

Collaborative nanocarrier formulation and R&D partnerships

Joint development projects with academic and industry partners to identify targets, optimize carrier formulations, and advance translational research for human, animal and plant applications.

Transfection reagent supply and protocol support

Provision of peptide-based transfection reagent kits and stepwise protocols including N/P ratio guidance and complexation procedures for cell transfection experiments.

Preclinical testing and characterization services

Analytical and biological testing services including in vitro transfection assays, cytotoxicity testing, biodistribution studies, and stability/toxicology evaluations to support product development.

Expertise Areas

  • Peptide nanoparticle development
  • Nucleic acid delivery and transfection
  • Formulation for shelf-stable mRNA
  • Biopesticide (RNAi) delivery
  • Show More (4)

Key Technologies

  • Peptide-based nanoparticle design
  • Self-assembling branched amphipathic peptide capsules
  • Peptide colloid encapsulation
  • Nucleic acid delivery (siRNA, dsRNA, mRNA, plasmid, CRISPR components)
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.